Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss.

MLA

Lutze, Richard D., et al. “Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss.” Pharmaceuticals (14248247), vol. 17, no. 6, June 2024, p. 735. EBSCOhost, https://doi.org/10.3390/ph17060735.

APA

Lutze, R. D., Ingersoll, M. A., Kelmann, R. G., & Teitz, T. (2024). Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss. Pharmaceuticals (14248247), 17(6), 735. https://doi.org/10.3390/ph17060735

Chicago

Lutze, Richard D., Matthew A. Ingersoll, Regina G. Kelmann, and Tal Teitz. 2024. “Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss.” Pharmaceuticals (14248247) 17 (6): 735. doi:10.3390/ph17060735.